Movember is proud to announce new funding set to revolutionise Australian prostate cancer research.

Prostate cancer research in Australia will reach new heights over the next five years as Movember and Prostate Cancer Foundation of Australia (PCFA) launch a new multi-million dollar research venture to deliver more opportunities to existing and future researchers in the prostate cancer field, including the new $5.25m Movember Revolutionary Team Award.

Funded exclusively by Mo Bros and Mo Sistas, two Movember Revolutionary Team Awards will be granted in 2013, totalling $10.5m. This significant initiative is part of Movember’s global research strategy to build powerful, collaborative teams that accelerates improved clinical tests and treatments for prostate cancer.

“We are humbled by the extraordinary efforts of Mo Bros and Mo Sistas around the globe, who not only raise funds but awareness for men’s health. The Australian Mo’s can stand proud today, as the money they’ve worked so hard to sprout and grow is committed to this revolutionary approach to prostate cancer research” said Jason Hincks, Movember COO.

The Movember Revolutionary Team Award will see the development of two multi-institutional teams who will dedicate their time to developing new targeted treatments for metastatic disease, address resistance issues of advanced prostate cancer, seek new treatment options for advanced prostate cancer, and to tackle the critical challenges associated with localised disease.

Dr Anthony Lowe, Chief Executive of PCFA said “Thanks to the generosity of the Movember Foundation, PCFA has been able to invest over $30 million into research projects across the country. We are thrilled to be getting another awards program off the ground”.

Movember is committed to supporting a game-changing approach to the way prostate cancer research is undertaken in Australia. “A Movember Revolutionary Team must demonstrate that the whole team working together as one will be greater than the sum of the parts. This award seeks to transform the clinical management of prostate cancer by supporting scientific and clinical teams across institutions that are committed to this approach” said Paul Villanti, Movember’s Executive Director Programs.
 
The chosen teams will receive funding over three years with renewal based on an international peer review process.

Investigators, scientists and clinicians who would like to apply for the Movember Revolutionary Team Award will need to submit a notice of intent to apply by Friday 5 July 2013. Full details of the submission process will be available on PCFA’s Research program website on Monday 11th June 2013.